Skip to main content

Model Organisms to Verify Vaccine Against Human Diseases

 Verification of vaccine efficacy is necessary as it shows how well a candidate vaccine works in humans. However, testing vaccine efficacy in humans is costly, time-consuming, and complex because it may involve a large number of participants who might have geographic or demographic biases and it requires following cohorts of subjects for years to monitor protective efficacy. Moreover, vaccine efficacy studies in humans could get trouble in ethical issues when it comes to certain pathogens like HIV. Contrarily, model organisms, which are easy to maintain and breed in a laboratory setting with a short generation time, permit faster evaluation of promising vaccine candidates at a lower cost and risk compared with humans.

 

Some model organisms have similar genes or similar-sized genomes to humans, which means they can mimic the pathophysiology of human disease after being infected by a target pathogen and bear a resemblance to human immune responses. Theoretically, the immune system of model organisms and humans share most underlying principles in terms of genome function. Therefore, a wide range of subjects, including virology, bacteriology, parasitology, and dermatology, take advantage of immunology antibodies generated in model organisms to verify and evaluate vaccine efficacy against human diseases.

 

Researchers from Yale University and the University of Pennsylvania recently published a study in Science Translational Medicine, introducing an mRNA-based vaccine that aims to prevent Lyme disease by deterring the tick itself. Lyme disease is a vector-borne disease caused by Borrelia burgdorferi, a bacterium carried and passed into the bloodstream by ticks when ticks bite human skin. A new approach was taken to develop a vaccination against Lyme disease, which is not targeting the pathogen but the tick vector. Researchers packaged 19 mRNAs, which encoded proteins expressed in tick saliva, into lipid nanoparticles and injected them into the host. mRNAs would be translated into proteins in the host, and then elicit an protective immune response through antibody generation.

 

In this study, researchers used guinea pigs as model organisms to verify the vaccine efficacy against Lyme disease. After the model organism was immunized with the mRNA vaccine, guinea pig antibodies against many of the selected proteins in the vaccine were generated, indicating the vaccination has elicited a immune response in the host. Compared to unvaccinated guinea pigs, vaccinated model guinea pigs appear early erythema or obvious reddening of the skin at the bite site. It's inspiring because these symptoms make it easier for 70% of people who never noticed the tick bite to identify and remove the tick from the skin before the transmission of the disease-causing bacterium. Besides, signs of tick immunity, such as tick rejection, poor tick feeding, and detachment, were also observed on the vaccinated guinea pigs.

 

Generally, studies using animal models have achieved varying degrees of success had in predicting therapeutics and vaccine outcomes in human studies. For instance, model organism antibodies have been widely adopted in the development of therapeutics. And in the design and evaluation of vaccines against human diseases, such as early-generation DNA vaccines and viral vector-based approaches, promising research results are yielded in animal models.

Labels:

Comments

Post a Comment

Popular posts from this blog

How Haptens Differ from Antigens and Become Immunogens?

The  difference between antigens vs. haptens  is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.   What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.   What are Antigens? Antigen s, including proteins, peptides, and polysaccharides, are immunogen   molecules  that can trigger immune response s or naturally bind to   immune   components . An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibod...
Post a Comment
Read more

Review: Creative Biolabs' Model-org Antibodies Fluorescently Labeling Services

Model organisms (Model-org) are non-human species, from which researchers can get insights into other organisms in biological research processes. Various model organism species such as zebrafish, flies, yeast, and rice, greatly contribute to the basic and clinical research in animal husbandry, fishery ， agriculture, forestry, etc.   Investigations on model organisms can be aided by antibody labeling when samples of interest need to be detected, isolated, or purified, though the selection of a proper label can be a challenge.   To select the best antibody labeling way for our Model-org project, we then found Creative Biolabs, one of the most well-established CROs for antibody development. After a comprehensive discussion and consultancy with the scientists at Creative Biolabs, fluorescent tags were  suggested based on our research direction. Fluorescent labels are directly conjugated to the antibody of interest, indicating that we can directly detect the number of fluoresc...
Post a Comment
Read more

Metagenomics Enhances Infectious Disease Surveillance

  Infectious lower respiratory diseases and diarrheal diseases are the leading causes of death globally . And the ongoing COVID-19 pandemic, which has contributed to 4.1 million deaths in 2019, once again is reminding the necessity of proactively identifying early signs of infectious disease outbreaks before things are getting worse. Conventional microbial diagnostics techniques would identify pathogens under specific culture conditions by serological detection of pathogen-associated antibodies or microbial genetic investigation using PCR, but these methods have been seen obvious shortcomings in pathogen coverage. It's highly required to find advanced scientific tools that are more sensitive even with a low microbial load or when targeted microorganisms are not suitable for  in vitro  culture, for which metagenomic approaches that can profile all DNA or RNA of a patient sample are increasingly catching the eyes of researchers.   How metagenomics can be used in infect...
Post a Comment
Read more